| 期刊論文1. | 陳寶妃、紀廣明、陳耀德、蔡玲珊、施伶宜、林麗珠、陳秀熙、盧勝男(20061200)。慢性B型肝炎、C型肝炎盛行率及ALT異常率之村里別分佈及地理差異:臺南縣520個村里之成人健檢分析。內科學誌,17(6),276-290。 延伸查詢 | 2. | Sun, C. A.、Chen, H. C.、Lu, S. N.(2001)。Persistent hyperendemicity of hepatitis c virus infection in Taiwan: The important role of iatrogenic risk factors。Journal of Medical Virology,65,30-34。 | 3. | Ho, M. S.、Hsu, C. P.、Yuh, Y.(1997)。High rate of hepatitis C virus infection in an isolated community: persistent hyperendemicity or period-related phenomena?。J Med Virol,52,370-376。 | 4. | Chen, Chien-hung、Yang, Pei-ming、Huang, Guan-tarn、Lee, Hsuan-shu、Sung, Juei-low、Sheu, Jin-chuan(20070200)。Estimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening Participants。Journal of the Formosan Medical Association,106(2),148-155。 | 5. | Chen, T. Z.、Wu, J. C.、Yen, F. S.(1995)。Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan。J Med Virol,46(3),247-251。 | 6. | 劉嘉玲、楊雯雯、吳慧敏、鄭國本、蒲若芳(2019)。台灣C型肝炎消除的國家政策與軌跡。愛之關懷季刊,109,6-16。 延伸查詢 | 7. | Tsai, M. C.、Kee, K. M.、Chen, Y. D.(2007)。Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan。J Gastroenterol Hepatol,22,92-98。 | 8. | Chen, Y. Y.、Chen, C. L.、Chen, J. W.(2020)。Secular trends and geographic maps of hepatitis C virus Infection among 4 Million Blood Donors in Taiwan from 1999 to 2017。Hepatol Commun,4,1193-1205。 | 9. | Su, W. W.、Chen, C. H.、Lin, H. H.(2009)。Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas。Hepatol Int,3,537-543。 | 10. | Tung, Hung-da、Lee, Pei-lun、Chen, Jyh-jou、Kuo, Hsing-tao、Sheu, Ming-jen、Cheng, Chun-ta、Chuang, Tang-wei、Kao, Hsu-ju、Hou, Chia-yi、Tsai, Hsin-hua、Wu, Li-ching、Lee, Chuan(20201200)。Geographic Variation of Genotype 6 Hepatitis C Virus Infection in an Endemic Area of Southern Taiwan。Journal of the Formosan Medical Association,119(12),1876-1880。 | 11. | Wu, Grace Hui-min、Yang, Wen-wen、Liu, Chia-ling、Pwu, Raoh-fang、Chien, Rong-nan、Lee, Po-chang、Chen, Shih-chung、Chen, Ding-shinn、Lu, Sheng-nan(20210700)。The Epidemiological Profile of Chronic Hepatitis C with Advanced Hepatic Fibrosis Regarding Virus Genotype in Taiwan: A Nationwide Study。Journal of the Formosan Medical Association,120(7),1444-1451。 | 12. | Yang, T. H.、Fang, Y. J.、Hsu, S. J.(2020)。Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan。Open Forum Infect Dis,7。 | 13. | Yu, M. L.、Chuang, W. L.、Chen, S. C.(2001)。Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan。J Med Virol,65,58-65。 | 14. | Chen, Wei-ming、Lee, Chih-yi、Hsu, Nien-tzu、Huang, Wei-cheng、Chen, Mei-yen、Huang, Tung-jung、Lu, Sheng-nan(20210500)。Feasibility of Anti-HCV Reflex HCV Ag Screening Strategy in an HCV Endemic Community。Journal of the Formosan Medical Association,120(5),1237-1241。 | 15. | 蘇湘雲(2020)。精準篩檢,全方位減少C型肝炎威脅--消除C型肝炎超前部署。衛福季刊,26,26-29。 延伸查詢 | 16. | Kuo, Y. H.、Chen, P. F.、Wang, J. H.(2015)。Comparison stratagems of post-screening management of anti-HCV-positive community residents: simple notification, active referral, or accessible medical care。PLoS One,10。 | 17. | 葉彥伯、王曉琪、柯淑瑜、郭重揚、宋曼麗(2019)。彰化縣C肝根除領先鋒--“三年減半,六年根除”的全方位策略。愛之關懷季刊,109,17-25。 延伸查詢 | 18. | Lin, Kuan-yin、Sun, Hsin-yun、Lee, Tai-fen、Chuang, Yu-chung、Wu, Un-in、Liu, Wen-chun、Chang, Sui-yuan、Chen, Yi-jing、Hung, Chien-ching、Chang, Shan-chwen(20211000)。High Prevalence of Sexually Transmitted Coinfections among At-risk People Living with HIV。Journal of the Formosan Medical Association,120(10),1876-1883。 | 19. | Ho, S. Y.、Su, L. H.、Sun, H. Y.(2020)。Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011-2018。EClinicalMedicine,24。 | 20. | Yu, M. L.、Huang, C. F.、Wei, Y. J.(2021)。Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)。Gut,70(12),2349-2358。 | 21. | Huang, C. F.、Chiu, Y. W.、Yu, M. L.(2020)。Patient-centered outreach treatment toward micro-elimination of hepatitis C virus infection in hemodialysis patients。Kidney Int,97。 | 22. | Tai, Chi-ming、Yen, Yung-chieh、Bair, Ming-jong、Tseng, Cheng-hao、Chang, Ting-ting、Huang, Chung-feng、Yeh, Ming-lun、Dai, Chia-yen、Chuang, Wan-long、Yu, Ming-lung、Huang, Jee-fu(20190800)。Integrated Care for Methadone Maintenance Patients with Hepatitis C Virus Infection。The Kaohsiung Journal of Medical Sciences,35(8),501-507。 | 23. | Wang, C. S.、Chang, Ting-Tung、Chou, P.(1998)。Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan。Journal of Clinical Epidemiology,51(9),733-738。 | 研究報告1. | 衛生福利部。國家消除C肝辦公室統計資訊。 延伸查詢 | 圖書1. | 國家消除C肝政策綱領編輯團隊(2019)。國家消除C肝政策綱領2018-2025。衛生福利部。 延伸查詢 | 其他1. | 衛生福利部。C型肝炎原鄉微消除經驗分享,https://www.mohw.gov.tw/cp-4463-52938-1.html。 延伸查詢 | 2. | WHO(2016)。Global Health Sector Strategy on Viral Hepatitis, 2016-2021: Towards Ending Viral Hepatitis,WHO。 | |
| |